DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop. Issue 1 (January 2019)

• Record Type: Journal Article
• Authors: Vella, Veronica; Nicolosi, Maria Luisa; Cantafio, Patrizia; Massimino, Michele; Lappano, Rosamaria; Vigneri, Paolo; Ciuni, Roberto; Gangemi, Pietro; Morrione, Andrea; Malaguarnera, Roberta; Belfiore, Antonino
• Is Part Of: Endocrine-related cancer. Volume 26:Issue 1(2019)
• Page Start: 197
• Page End: 214
• Publication Date: 2019-01
• Subjects: thyroid cancer -- Discoidin Domain Receptor 1 -- insulin receptor isoform-A -- insulin-like growth factor-2; Endocrine glands -- Cancer -- Periodicals; Endocrinology -- Periodicals; Cancer -- Endocrine aspects -- Periodicals; 616.9944005
• DOI: 10.1530/ERC-18-0310
• Languages: English
• ISSNs: 1351-0088

Abstract

Abstract : Patients with thyroid cancers refractory to radioiodine (RAI) treatment show a limited response to various therapeutic options and a low survival rate. The recent use of multikinase inhibitors has also met limited success. An alternative approach relies on drugs that induce cell differentiation, as the ensuing increased expression of the cotransporter for sodium and iodine (NIS) may partially restore sensitivity to radioiodine. The inhibition of the ERK1/2 pathway has shown some efficacy in this context. Aggressive thyroid tumors overexpress the isoform-A of the insulin receptor (IR-A) and its ligand IGF-2; this IGF-2/IR-A loop is associated with de-differentiation and stem-like phenotype, resembling RAI-refractory tumors. Importantly, IR-A has been shown to be positively modulated by the non-integrin collagen receptor DDR1 in human breast cancer. Using undifferentiated human thyroid cancer cells, we now evaluated the effects of DDR1 on IGF-2/IR-A loop and on markers of cell differentiation and stemness. DDR1 silencing or downregulation caused significant reduction of IR-A and IGF-2 expression, and concomitant increased levels of differentiation markers (NIS, Tg, TSH, TPO). Conversely, markers of epithelial-to-mesenchymal transition (Vimentin, Snail-2, Zeb1, Zeb2 and N-Cadherin) and stemness (OCT-4, SOX-2, ABCG2 and Nanog) decreased. These effects were collagen independent. In contrast, overexpression of either DDR1 or its kinase-inactive variant K618A DDR1-induced changes suggestive of less differentiated and stem-like phenotype. Collagen stimulation was uneffective. In conclusion, in poorly differentiated thyroid cancer, DDR1 silencing or downregulation blocks the IGF-2/IR-A autocrine loop and induces cellular differentiation. These results may open novel therapeutic approaches for thyroid cancer.